Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
about
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersElevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial CarcinomaTargeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'?Design, synthesis and biological evaluation of deuterated nintedanib for improving pharmacokinetic properties.
P2860
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
@en
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
@nl
type
label
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
@en
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
@nl
prefLabel
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
@en
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
@nl
P2860
P1476
Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?
@en
P2093
Matthew R Smith
Richard J Lee
P2860
P304
P356
10.1158/1078-0432.CCR-13-2636
P407
P577
2013-11-27T00:00:00Z